|
WASF1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.9322999584025E-09 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.1430000000049E-05 |
| Normal-vs-Stage2 |
5.643400E-03 |
| Normal-vs-Stage3 |
1.039980E-03 |
| Normal-vs-Stage4 |
3.097800E-03 |
| Stage1-vs-Stage2 |
1.492770E-01 |
| Stage1-vs-Stage3 |
1.681590E-02 |
| Stage1-vs-Stage4 |
1.851570E-02 |
| Stage2-vs-Stage3 |
1.232370E-01 |
| Stage2-vs-Stage4 |
5.621900E-02 |
| Stage3-vs-Stage4 |
8.397600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.48009998385868E-09 |
| Normal-vs-AfricanAmerican |
7.411000E-04 |
| Normal-vs-Asian |
1.070450E-01 |
| Caucasian-vs-AfricanAmerican |
9.283400E-01 |
| Caucasian-vs-Asian |
9.027000E-01 |
| AfricanAmerican-vs-Asian |
8.981200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.61390000042294E-07 |
| Normal-vs-Female |
2.00180000020644E-07 |
| Male-vs-Female |
5.460200E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.597400E-03 |
| Normal-vs-Extreme_Weight |
4.967300E-04 |
| Normal-vs-Obese |
2.5271000000382E-06 |
| Normal-vs-Extreme_Obese |
1.759580E-01 |
| Normal_Weight-vs-Extreme_Weight |
1.184000E-01 |
| Normal_Weight-vs-Obese |
6.678400E-01 |
| Normal_Weight-vs-Extreme_Obese |
5.173400E-01 |
| Extreme_Weight-vs-Obese |
5.109700E-02 |
| Extreme_Weight-vs-Extreme_Obese |
7.933600E-01 |
| Obese-vs-Extreme_Obese |
4.913000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.423240E-04 |
| Normal-vs-Age(41-60Yrs) |
9.80999947941541E-10 |
| Normal-vs-Age(61-80Yrs) |
1.399370E-04 |
| Normal-vs-Age(81-100Yrs) |
1.499410E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.749740E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.636140E-03 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.559700E-03 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.614000E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.326600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.698200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
8.09930000844616E-09 |
| Normal-VS-Type2 PRCC |
2.744600E-03 |
| Normal-VS-KIRP CIMP |
7.249500E-04 |
| Normal-VS-Unclassified PRCC |
2.877600E-03 |
| Type1 PRCC-VS-Type2 PRCC |
9.784400E-01 |
| Type1 PRCC-VS-KIRP CIMP |
5.223400E-03 |
| Type1 PRCC-VS-Unclassified PRCC |
5.413400E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.821860E-03 |
| Type2 PRCC-VS-Unclassified PRCC |
7.170000E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
3.517000E-03 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.968800E-04 |
| Normal-vs-N1 |
2.248900E-04 |
| Normal-vs-N2 |
8.559600E-02 |
| N0-vs-N1 |
3.438100E-03 |
| N0-vs-N2 |
1.408420E-01 |
| N1-vs-N2 |
4.224400E-01 |
|
|
